BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32820849)

  • 41. Methotrexate Treatment for Pityriasis Rubra Pilaris: A Case Series and Literature Review.
    Koch L; Schöffl C; Aberer W; Massone C
    Acta Derm Venereol; 2018 Apr; 98(5):501-505. PubMed ID: 29335741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of ustekinumab after failure of infliximab CT-P13 in a HLA-Cw6-positive patient affected by pityriasis rubra pilaris: monitoring with reflectance confocal microscopy (RCM) and optical coherence tomography (OCT).
    Paganelli A; Ciardo S; Odorici G; Pellacani G; Conti A
    J Eur Acad Dermatol Venereol; 2017 May; 31(5):e249-e251. PubMed ID: 27739122
    [No Abstract]   [Full Text] [Related]  

  • 43. Pityriasis rubra pilaris partially responsive to treatment with upadacitinib: A case report.
    Saad M; Spurr A; Lipson J
    SAGE Open Med Case Rep; 2023; 11():2050313X231160927. PubMed ID: 37009550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment of erythrodermic pityriasis rubra pilaris with acitretin.
    Atzori L; Zanniello R; Lappi A; Pinna AL; Ferreli C; Rongioletti F; Pilloni L
    Dermatol Ther; 2018 Sep; 31(5):e12694. PubMed ID: 30230135
    [No Abstract]   [Full Text] [Related]  

  • 45. Pityriasis rubra pilaris: a rare inflammatory dermatosis.
    Kelly A; Lally A
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29440245
    [No Abstract]   [Full Text] [Related]  

  • 46. Systemic sclerosis in a patient with pityriasis rubra pilaris.
    Frikha F; Frigui M; Masmoudi H; Turki H; Bahloul Z
    Pan Afr Med J; 2010 Aug; 6():6. PubMed ID: 21436949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment Options for Juvenile Pityriasis Rubra Pilaris.
    Guenther J; Novack D; Kamath S; Worswick S
    Paediatr Drugs; 2023 Mar; 25(2):151-164. PubMed ID: 36529810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful treatment of type I adult-onset pityriasis rubra pilaris with infliximab.
    Manoharan S; White S; Gumparthy K
    Australas J Dermatol; 2006 May; 47(2):124-9. PubMed ID: 16637810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adult onset pityriasis rubra pilaris.
    Sehgal VN; Srivastava G; Dogra S
    Indian J Dermatol Venereol Leprol; 2008; 74(4):311-21. PubMed ID: 18797049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A child with CARD14-associated papulosquamous eruption (CAPE) successfully treated with ustekinumab.
    Nogueira M; Reis J; Abreu M; Coelho A; Reis CF; Machado S
    Pediatr Dermatol; 2023; 40(6):1104-1106. PubMed ID: 37219506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pityriasis rubra pilaris with erythema gyratum repens-like eruption and resolution with ustekinumab.
    Wong JY; Surgenor L; McCourt C
    Clin Exp Dermatol; 2022 Dec; 47(12):2300-2303. PubMed ID: 35978553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Follicular Psoriasis: Differentiation from Pityriasis Rubra Pilaris-An Illustrative Case and Review of the Literature.
    Nguyen CV; Farah RS; Maguiness SM; Miller DD
    Pediatr Dermatol; 2017 Jan; 34(1):e65-e68. PubMed ID: 27874201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pityriasis rubra pilaris: treatment with biologics - a new promising therapy?
    Ivanova K; Itin P; Haeusermann P
    Dermatology; 2012; 224(2):120-5. PubMed ID: 22508269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pityriasis Rubra Pilaris in a 3-Year-Old Male.
    Stacey SK; Novek SJ; Maddox CL
    Mil Med; 2016 Mar; 181(3):e298-301. PubMed ID: 26926758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case of pityriasis rubra pilaris treated with tofacitinib after failure with acitretin and ixekizumab.
    Ying Y; Yu-Hua L; Xiao-Yan W; Su-Chun H
    Australas J Dermatol; 2023 Aug; 64(3):445-447. PubMed ID: 37200390
    [No Abstract]   [Full Text] [Related]  

  • 56. Pityriasis rubra pilaris in black South Africans.
    Jacyk WK
    Clin Exp Dermatol; 1999 May; 24(3):160-3. PubMed ID: 10354168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pityriasis rubra pilaris after COVID-19 vaccination: successful treatment with ustekinumab.
    Vieira Granja B; Amoedo P; Gomes NP; Costa C; Azevedo F; Magina S
    An Bras Dermatol; 2024; 99(4):642-644. PubMed ID: 38653608
    [No Abstract]   [Full Text] [Related]  

  • 58. A case of classic adult pityriasis rubra pilaris successfully treated with a combination of acitretin and ustekinumab: A case report.
    DeBiasio C; Cyr J; Ayroud Y; Glassman SJ
    SAGE Open Med Case Rep; 2022; 10():2050313X221093453. PubMed ID: 35465019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful treatment of pityriasis rubra pilaris with adalimumab - case report.
    Bravo EA; Carrion L; Paucar SM; Mendoza R; Rivera C
    Dermatol Online J; 2014 Apr; 20(4):22374. PubMed ID: 24746310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful treatment of CARD14-negative juvenile Pityriasis rubra pilaris with Ustekinumab.
    Reitmajer M; Forchhammer S; Silber T
    J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e512-e514. PubMed ID: 38084925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.